Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

AIMS: As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Heart J
Autori principali: Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B., Brunner, Fabian J., Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M., Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G., Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Meta-Analysis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837491/
https://ncbi.nlm.nih.gov/pubmed/28449027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx166
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi